Soleno Therapeutics, Inc. (SLNO) Tops Q2 EPS by 2c

Soleno Therapeutics, Inc. (NASDAQ: SLNO) reported Q2 EPS of ($0.57), $0.02 better than the analyst estimate of ($0.59).

For earnings history and earnings-related data on Soleno Therapeutics, Inc. (SLNO) click here.

You May Also Be Interested In

• Bessent: U.S. will enforce 'zero leakage' approach to Iran sanctions
• XPeng (XPEV) PT Lowered to $18 at Bernstein SocGen Group
• Trump: Lots of bluster from Ontario's Doug Ford